Kamal MA - Search Results

1

Kinetic analysis of the inhibition of human butyrylcholinesterase with cymserine.

Kamal MA, Al-Jafari AA, Yu QS, Greig NH. Kamal MA, et al. Biochim Biophys Acta. 2006 Feb;1760(2):200-6. doi: 10.1016/j.bbagen.2005.10.003. Epub 2005 Oct 27. Biochim Biophys Acta. 2006. PMID: 16309845

2

Kinetics of human serum butyrylcholinesterase inhibition by a novel experimental Alzheimer therapeutic, dihydrobenzodioxepine cymserine.

Kamal MA, Klein P, Luo W, Li Y, Holloway HW, Tweedie D, Greig NH. Kamal MA, et al. Neurochem Res. 2008 May;33(5):745-53. doi: 10.1007/s11064-007-9490-y. Epub 2007 Nov 6. Neurochem Res. 2008. PMID: 17985237 Free PMC article.

3

Tetrahydrofurobenzofuran cymserine, a potent butyrylcholinesterase inhibitor and experimental Alzheimer drug candidate, enzyme kinetic analysis.

Kamal MA, Qu X, Yu QS, Tweedie D, Holloway HW, Li Y, Tan Y, Greig NH. Kamal MA, et al. J Neural Transm (Vienna). 2008 Jun;115(6):889-98. doi: 10.1007/s00702-008-0022-y. Epub 2008 Jan 31. J Neural Transm (Vienna). 2008. PMID: 18235987 Free PMC article.

4

Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus.

Mushtaq G, Greig NH, Khan JA, Kamal MA. Mushtaq G, et al. Among authors: kamal ma. CNS Neurol Disord Drug Targets. 2014;13(8):1432-9. doi: 10.2174/1871527313666141023141545. CNS Neurol Disord Drug Targets. 2014. PMID: 25345511 Free PMC article. Review.

5

Inhibition of Butyrylcholinesterase with Fluorobenzylcymserine, An Experimental Alzheimer's Drug Candidate: Validation of Enzoinformatics Results by Classical and Innovative Enzyme Kinetic Analyses.

Kamal MA, Shakil S, Nawaz MS, Yu QS, Tweedie D, Tan Y, Qu X, Greig NH. Kamal MA, et al. CNS Neurol Disord Drug Targets. 2017;16(7):820-827. doi: 10.2174/1871527316666170207160606. CNS Neurol Disord Drug Targets. 2017. PMID: 28176640 Free PMC article.

6

The preparation and kinetic analysis of multiple forms of human erythrocyte acetylcholinesterase.

Kamal MA, al-Jafari AA. Kamal MA, et al. Prep Biochem Biotechnol. 1996 May;26(2):105-19. doi: 10.1080/10826069608000057. Prep Biochem Biotechnol. 1996. PMID: 8784921

7

Kinetics of human erythrocyte acetylcholinesterase inhibition by a novel derivative of physostigmine: phenserine.

al-Jafari AA, Kamal MA, Greig NH, Alhomida AS, Perry ER. al-Jafari AA, et al. Among authors: kamal ma. Biochem Biophys Res Commun. 1998 Jul 9;248(1):180-5. doi: 10.1006/bbrc.1998.8931. Biochem Biophys Res Commun. 1998. PMID: 9675107

8

Kinetic constants for the inhibition of camel retinal acetylcholinesterase by the carbamate insecticide lannate.

Kamal MA, Al-jafari AA. Kamal MA, et al. J Biochem Mol Toxicol. 1999;13(1):41-6. doi: 10.1002/(sici)1099-0461(1999)13:1<41::aid-jbt5>3.0.co;2-f. J Biochem Mol Toxicol. 1999. PMID: 9890446

9

Human erythrocyte acetylcholinesterase inhibition by cis-diamminediaquaplatinum (II): a novel kinetic approach.

Kamal MA, Nasim FH, Al-Jafari AA. Kamal MA, et al. Cancer Lett. 1999 Apr 26;138(1-2):115-9. doi: 10.1016/s0304-3835(98)00385-1. Cancer Lett. 1999. PMID: 10378782

10

Kinetics of human acetylcholinesterase inhibition by the novel experimental Alzheimer therapeutic agent, tolserine.

Kamal MA, Greig NH, Alhomida AS, Al-Jafari AA. Kamal MA, et al. Biochem Pharmacol. 2000 Aug 15;60(4):561-70. doi: 10.1016/s0006-2952(00)00330-0. Biochem Pharmacol. 2000. PMID: 10874131

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

809 results

Search Page

Filters